ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.73
+0.35 (6.51%)
At close: Jul 20, 2026, 4:00 PM EDT
5.77
+0.04 (0.70%)
After-hours: Jul 20, 2026, 4:10 PM EDT
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $64.63 million as of July 20, 2026.
Market Cap
64.63M
Enterprise Value
-50.16M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.73
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $64.63M, a decrease of -64.69%. That is a compound annual growth rate of -65.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 64.63M | -16.23% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 70.83M |
| PMV Pharmaceuticals | 69.33M |
| XBiotech | 68.90M |
| Pliant Therapeutics | 67.47M |
| iBio, Inc. | 67.31M |
| Telomir Pharmaceuticals | 67.05M |
| OS Therapies | 66.36M |
| MediciNova | 65.71M |